相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding the minimum clinically important difference: a review of concepts and methods
Anne G. Copay et al.
SPINE JOURNAL (2007)
Report by the ACNP Task Force on response and remission in major depressive disorder
A. John Rush et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Comparing the effects of antidepressants: Consensus guidelines for evaluating quantitative reviews of antidepressant efficacy
JA Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care
UM Lepola et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
Effect of active treatment is lower when using placebo control in clinical trials on acute therapy of migraine
A Eikermann et al.
CEPHALALGIA (2003)
Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients
WJ Burke et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Baseline characteristics of major depressive disorder patients in clinical trials in Europe and United States: is there a transatlantic difference?
IA Niklson et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2001)
Affective disorders and suicide risk: A reexamination
JM Bostwick et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Psychosocial disability during the long-term course of unipolar major depressive disorder
LL Judd et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
分享论文
